About this Tool The Fasenra (benralizumab) Dosing Calculator is a clinical support tool designed to help healthcare professionals map out the administration schedule for patients with severe eosinophilic asthma. It calculates dates for both the initial loading phase and the subsequent maintenance phase based on the approved dosing regimen. Outputs Upon entering the required dates, … Read more
About this Information This section provides supporting information for the Adbry (tralokinumab) Dosing Calculator. It details the dosing regimens, administration instructions, and other clinical considerations based on the product’s prescribing information. This content is for educational purposes and should not replace clinical judgment or the official product label. Outputs The calculator provides tailored dosing recommendations … Read more
About This Tool This Siliq (brodalumab) Dosing Calculator is designed to help healthcare professionals understand the dosing schedule based on the Prescribing Information. It provides a visual and list-based timeline for the induction and maintenance phases of treatment for moderate-to-severe plaque psoriasis. Outputs Explained Upon entering a treatment start date, the calculator generates two key … Read more
(function() { function init() { const mountId = “pft-cosentyx-secukinumab-dosing-calculator-mount”; const wrapperId = “pft-cosentyx-secukinumab-dosing-calculator-tool”; const mount = document.getElementById(mountId); if (!mount) { console.error(“Calculator mount point not found.”); return; } try { const shadowRoot = mount.attachShadow({ mode: ‘open’ }); const wrapper = document.createElement(‘div’); wrapper.id = wrapperId; const cssTemplate = ` :host, #${wrapperId} { all: initial; display: block; font-family: … Read more
Guide to Tildrakizumab Dosing & Administration This guide provides supplementary information about the dosing schedule, administration, and clinical considerations for Ilumya (tildrakizumab) to support the use of the calculator. About The Ilumya (tildrakizumab) Dosing Calculator is a clinical support tool designed for healthcare professionals to quickly generate an administration schedule for patients with moderate-to-severe plaque … Read more
About This Tool The Tremfya (guselkumab) Dosing Calculator is a support tool designed for U.S. healthcare professionals to map out the FDA-approved dosing schedule for patients. It provides a clear timeline for both induction and maintenance phases based on the selected indication and, where applicable, patient weight. This tool serves as a supplementary resource and … Read more
About Avsola (infliximab-axxq) Dosing This information provides context for the Avsola (infliximab-axxq) Dosing Calculator. Avsola is a biosimilar to Remicade (infliximab) and is administered as an intravenous infusion. Dosing is weight-based and varies according to the specific indication, requiring careful calculation to ensure patient safety and therapeutic efficacy. The standard concentration after reconstitution is 10 … Read more
About This Guide This information serves as a companion guide to the Renflexis (infliximab-abda) Dosing Calculator calculator. It provides context on the calculator’s inputs, outputs, and the underlying dosing principles based on the FDA-approved Prescribing Information. This guide is for informational purposes and should not replace clinical judgment. Understanding the Calculator Outputs After entering the … Read more
About This Dosing Guide This guide provides supplementary information for the Inflectra (infliximab-dyyb) Dosing Calculator. It outlines the tool’s functions, the data it provides, and key clinical considerations based on the FDA-approved Prescribing Information. It is intended for healthcare professionals as a supportive resource and is not a substitute for clinical judgment or the official … Read more
About This Calculator The Amjevita (adalimumab-atto) Dosing Calculator is an educational resource designed for healthcare professionals to quickly determine recommended dosing schedules based on patient population, approved indication, and other relevant clinical factors. This guide provides supplementary information on how the tool functions, its outputs, and key dosing considerations based on the official prescribing information. … Read more
